{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:34:47Z","timestamp":1782459287543,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2022.1007762","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T17:29:01Z","timestamp":1662744541000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Editorial: Cancer therapy: The challenge of handling a double-edged sword"],"prefix":"10.3389","volume":"13","author":[{"given":"Kulmira","family":"Nurgali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Was","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Abalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"710163","DOI":"10.3389\/fonc.2021.710163","article-title":"Long-term effects of pediatric acute lymphoblastic leukemia chemotherapy: Can recent findings inform old strategies?","volume":"11","author":"Al-Mahayri","year":"2021","journal-title":"Front. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"701424","DOI":"10.3389\/fonc.2021.701424","article-title":"Case report: Paclitaxel-Induced pneumonitis in early breast cancer: A single institution experience and review","volume":"11","author":"Ardolino","year":"2021","journal-title":"Front. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"720776","DOI":"10.3389\/fphar.2021.720776","article-title":"Common immune-related adverse events of immune checkpoint inhibitors in the gastrointestinal system: A study based on the us food and drug administration adverse event reporting system","volume":"12","author":"Bai X","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"608218","DOI":"10.3389\/fphar.2020.608218","article-title":"Novel oxovanadium complex VO(hntdtsc)(NPIP): Anticancer activity and mechanism of action on HeLa cells","volume":"11","author":"Bai Y","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"734613","DOI":"10.3389\/fphar.2021.734613","article-title":"Cannabinoid drugs-related neuroprotection as a potential therapeutic tool against chemotherapy-induced cognitive impairment","volume":"12","author":"Boullon","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"601513","DOI":"10.3389\/fphar.2020.601513","article-title":"Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel","volume":"11","author":"Chang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"630921","DOI":"10.3389\/fonc.2021.630921","article-title":"Astragaloside IV and saponins of rhizoma polygonati cure cyclophosphamide-induced myelosuppression in lung adenocarcinoma via down-regulating miR-142-3p","volume":"11","author":"Gu","year":"2021","journal-title":"Front. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"726008","DOI":"10.3389\/fonc.2021.726008","article-title":"Incidence and risk of hypertension in cancer patients treated with atezolizumab and bevacizumab: A systematic review and meta-analysis","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"744085","DOI":"10.3389\/fphar.2021.744085","article-title":"Colorectal cancer survivors suffering from sensory chemotherapy-induced peripheral neuropathy are not a homogenous group: Secondary analysis of patients' profiles with oxaliplatin-induced peripheral neuropathy","volume":"12","author":"Kerckhove","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"763229","DOI":"10.3389\/fonc.2021.763229","article-title":"A systematic review and meta-analysis of the effectiveness of neuroprotectants for paclitaxel-induced peripheral neuropathy","volume":"11","author":"Leen","year":"2022","journal-title":"Front. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"718086","DOI":"10.3389\/fphar.2021.718086","article-title":"Interventions for preventing cardiotoxicity in breast cancer patients receiving trastuzumab: A systemic review and bayesian network meta-analysis","volume":"12","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B18","first-page":"619461","article-title":"Hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin with or without sorafenib as initial treatment for advanced hepatocellular carcinoma","volume-title":"Front. Oncol.","author":"Liang","year":"2021"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.3389\/978-2-88945-482-2","volume-title":"Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?","author":"Nurgali","year":"2018"},{"key":"B11","doi-asserted-by":"publisher","first-page":"738385","DOI":"10.3389\/fonc.2021.738385","article-title":"Escape from cisplatin-induced senescence of hypoxic lung cancer cells can Be overcome by hydroxychloroquine","volume":"11","author":"Olszewska","year":"2021","journal-title":"Front. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"743582","DOI":"10.3389\/fphar.2021.743582","article-title":"Pulmonary toxicities associated with the use of immune checkpoint inhibitors: An update from the immuno-oncology subgroup of the neutropenia, infection & myelosuppression study group of the multinational association for supportive care in cancer","volume":"12","author":"Rapoport","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"688231","DOI":"10.3389\/fonc.2021.688231","article-title":"Case report: Severe rashes associated with fruquintinib in a patient with metastatic colorectal cancer","volume":"11","author":"Shu","year":"2021","journal-title":"Front. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"746053","DOI":"10.3389\/fphar.2021.746053","article-title":"Insights into acute and delayed cisplatin-induced emesis from a microelectrode array, radiotelemetry and whole-body plethysmography study of suncus murinus (house musk shrew)","volume":"12","author":"Tu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"762288","DOI":"10.3389\/fonc.2021.762288","article-title":"Doxorubicin\/adriamycin monotherapy or plus ifosfamide in first-line treatment for advanced soft tissue sarcoma: A pooled analysis of randomized trials","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","article-title":"Mechanisms of chemotherapy-induced neurotoxicity","volume":"13","author":"Was","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"736842","DOI":"10.3389\/fphar.2021.736842","article-title":"The contribution of phospholipase C in vomiting in the least shrew (cryptotis parva) model of emesis","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T17:29:04Z","timestamp":1662744544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":20,"alternative-id":["10.3389\/fphar.2022.1007762"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1007762","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"1007762"}}